Sentiment-Signal
Score-Verlauf (90 Tage)
Stammdaten
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Unternehmen & Branche
| Name | Royalty Pharma plc |
|---|---|
| Ticker | RPRX |
| CIK | 0001802768 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 67709Q104 |
|---|---|
| ISIN | US67709Q1041 |
| Typ | Common Stock |
| Marktkapitalisierung | 21,19 Mrd. USD |
| Beta | 0,39 |
| Dividendenrendite | 0,90 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 2,378,193,000 | 770,947,000 | 1.78 | 19,620,780,000 | |
| 2025-09-30 | 10-Q | 609,291,000 | 288,217,000 | 0.67 | 19,347,280,000 | |
| 2025-06-30 | 10-Q | 578,665,000 | 30,176,000 | 0.07 | 18,323,000,000 | |
| 2025-03-31 | 10-Q | 568,247,000 | 238,349,000 | 0.55 | 17,608,256,000 | |
| 2024-12-31 | 10-K | 2,263,576,000 | 858,983,000 | 1.91 | 18,222,715,000 | |
| 2024-09-30 | 10-Q | 564,690,000 | 543,987,000 | 1.21 | 18,042,242,000 | |
| 2024-06-30 | 10-Q | 537,267,000 | 102,004,000 | 0.23 | 17,656,579,000 | |
| 2024-03-31 | 10-Q | 567,978,000 | 4,778,000 | 0.01 | 16,130,886,000 | |
| 2023-12-31 | 10-K | 2,354,554,000 | 1,134,834,000 | 2.53 | 16,381,851,000 | |
| 2023-09-30 | 10-Q | 536,313,000 | 72,114,000 | 0.16 | 15,855,524,000 | |
| 2023-06-30 | 10-Q | 538,202,000 | 227,625,000 | 0.50 | 17,121,482,000 | |
| 2023-03-31 | 10-Q | 683,971,000 | 340,755,000 | 0.76 | 17,074,121,000 | |
| 2022-12-31 | 10-K | 2,237,215,000 | 42,832,000 | 0.10 | 16,813,466,000 | |
| 2022-09-30 | 10-Q | 573,463,000 | 142,651,000 | 0.32 | 17,672,605,000 | |
| 2022-06-30 | 10-Q | 535,955,000 | 304,504,000 | 0.70 | 17,740,413,000 | |
| 2022-03-31 | 10-Q | 562,049,000 | 51,761,000 | 0.12 | 17,378,888,000 | |
| 2021-12-31 | 10-K | 2,289,463,000 | 619,728,000 | 1.49 | 17,515,865,000 | |
| 2021-09-30 | 10-Q | 585,773,000 | 101,929,000 | 0.24 | 17,732,358,000 | |
| 2021-06-30 | 10-Q | 554,963,000 | 440,776,000 | 1.08 | 16,514,913,000 | |
| 2021-03-31 | 10-Q | 573,027,000 | 69,119,000 | 0.18 | 15,914,088,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 55,274,069 | 0 | 55,274,069 | 2,135,790,095 | Neu | +100,0% | |
| Capital International Investors | 31,104,309 | 0 | 31,104,309 | 1,201,870,500 | Neu | +100,0% | |
| FMR LLC | 26,272,308 | 0 | 26,272,308 | 1,015,161,996 | Neu | +100,0% | |
| BlackRock, Inc. | 26,188,692 | 0 | 26,188,692 | 1,011,931,068 | Neu | +100,0% | |
| BAILLIE GIFFORD & CO | 17,008,768 | 0 | 17,008,768 | 657,218,795 | Neu | +100,0% | |
| Swedbank AB | 11,942,143 | 0 | 11,942,143 | 461,444,406 | Neu | +100,0% | |
| STATE STREET CORP | 10,649,641 | 0 | 10,649,641 | 411,502,128 | Neu | +100,0% | |
| VANGUARD GROUP INC | 9,934,612 | 0 | 9,934,612 | 383,873,407 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 7,719,843 | 0 | 7,719,843 | 297,465,419 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 5,360,665 | 0 | 5,360,665 | 207,136,096 | Neu | +100,0% | |
| VICTORY CAPITAL MANAGEMENT INC | 5,106,905 | 0 | 5,106,905 | 197,330,809 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 5,042,709 | 0 | 5,042,709 | 194,850,276 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 4,003,322 | 0 | 4,003,322 | 154,688,363 | Neu | +100,0% | |
| NORGES BANK | 3,414,165 | 0 | 3,414,165 | 131,923,336 | Neu | +100,0% | |
| Patient Capital Management, LLC | 3,333,675 | 0 | 3,333,675 | 128,813,194 | Neu | +100,0% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3,313,265 | 0 | 3,313,265 | 128,024,560 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3,118,865 | 0 | 3,118,865 | 120,512,944 | Neu | +100,0% | |
| Legal & General Group Plc | 3,088,098 | 0 | 3,088,098 | 119,324,106 | Neu | +100,0% | |
| NEW SOUTH CAPITAL MANAGEMENT INC | 2,928,778 | 0 | 2,928,778 | 113,167,982 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,913,398 | 0 | 2,913,398 | 112,573,699 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 2,708,925 | 0 | 2,708,925 | 104,672,844 | Neu | +100,0% | |
| Regal Partners Ltd | 2,640,708 | 0 | 2,640,708 | 102,036,956 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 2,563,654 | 0 | 2,563,654 | 99,059,574 | Neu | +100,0% | |
| Qube Research & Technologies Ltd | 2,469,181 | 0 | 2,469,181 | 95,409,154 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 2,312,128 | 0 | 2,312,128 | 89,353,846 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 2,185,079 | 0 | 2,185,079 | 84,431,452 | Neu | +100,0% | |
| UBS Group AG | 2,005,831 | 0 | 2,005,831 | 77,505,310 | Neu | +100,0% | |
| HOMESTEAD ADVISERS CORP | 1,671,542 | 0 | 1,671,542 | 64,588,383 | Neu | +100,0% | |
| Brandywine Global Investment Management, LLC | 1,579,252 | 0 | 1,579,252 | 61,022,297 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1,575,900 | 0 | 1,575,900 | 60,892,777 | Neu | +100,0% | |
| Squarepoint Ops LLC | 1,556,241 | 0 | 1,556,241 | 60,133,152 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 1,518,610 | 0 | 1,518,610 | 58,679,167 | Neu | +100,0% | |
| Invesco Ltd. | 1,502,171 | 0 | 1,502,171 | 58,043,882 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 1,467,599 | 0 | 1,467,599 | 56,760,405 | Neu | +100,0% | |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 1,229,036 | 0 | 1,229,036 | 45,400,589 | Neu | +100,0% | |
| PFA Pension, Forsikringsaktieselskab | 1,118,023 | 0 | 1,118,023 | 43,591,729 | Neu | +100,0% | |
| Swiss National Bank | 1,125,400 | 0 | 1,125,400 | 43,485,456 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 1,065,103 | 0 | 1,065,103 | 41,155,580 | Neu | +100,0% | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 1,042,149 | 0 | 1,042,149 | 40,268,637 | Neu | +100,0% | |
| WEDGE CAPITAL MANAGEMENT L L P/NC | 1,039,968 | 0 | 1,039,968 | 40,184,364 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 1,020,768 | 0 | 1,020,768 | 39,442,476 | Neu | +100,0% | |
| Robeco Institutional Asset Management B.V. | 949,472 | 0 | 949,472 | 36,687,601 | Neu | +100,0% | |
| TUDOR INVESTMENT CORP ET AL | 924,819 | 0 | 924,819 | 35,735,006 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 838,613 | 0 | 838,613 | 32,404,007 | Neu | +100,0% | |
| NORDEA INVESTMENT MANAGEMENT AB | 812,663 | 0 | 812,663 | 31,604,464 | Neu | +100,0% | |
| Ensign Peak Advisors, Inc | 790,302 | 0 | 790,302 | 30,537,269 | Neu | +100,0% | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 781,519 | 0 | 781,519 | 30,197,894 | Neu | +100,0% | |
| TORRAY INVESTMENT PARTNERS LLC | 744,355 | 0 | 744,355 | 28,761,889 | Neu | +100,0% | |
| Capital International, Inc./CA/ | 739,185 | 0 | 739,185 | 28,562,108 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 681,248 | 0 | 681,248 | 26,323,423 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -32,916 | 48.33 | -1,590,889.53 | -148,8% | |
| 2026-04-01 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -1,875 | 48.33 | -90,622.13 | -8,5% | |
| 2026-03-23 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -1,875 | 45.53 | -85,366.31 | -8,0% | |
| 2026-03-23 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -32,916 | 45.53 | -1,498,622.69 | -140,2% | |
| 2026-03-02 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -1,292 | 46.67 | -60,303.71 | -5,6% | |
| 2026-03-02 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -22,487 | 46.67 | -1,049,506.52 | -98,2% | |
| 2026-03-02 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -10,429 | 47.01 | -490,314.22 | -45,9% | |
| 2026-03-02 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -583 | 47.01 | -27,409.34 | -2,6% | |
| 2026-02-23 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -32,916 | 45.32 | -1,491,637.91 | -139,5% | |
| 2026-02-23 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -1,875 | 45.32 | -84,968.44 | -7,9% | |
| 2026-02-04 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -19,076 | 43.29 | -825,853.45 | -77,2% | |
| 2026-02-04 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -1,087 | 43.29 | -47,059.27 | -4,4% | |
| 2026-02-03 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -108,759 | 42.84 | -4,659,583.59 | -435,8% | |
| 2026-02-03 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -6,195 | 42.84 | -265,413.00 | -24,8% | |
| 2026-02-02 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -102,581 | 42.08 | -4,317,008.55 | -403,8% | |
| 2026-02-02 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -5,843 | 42.08 | -245,896.23 | -23,0% | |
| 2026-01-30 | Urist Marshall | Officer, EVP, Research & Investments | Open Market Sale | -20,000 | 41.09 | -821,810.00 | -76,9% | |
| 2026-01-23 | Urist Marshall | Officer, EVP, Research & Investments | Open Market Sale | -20,000 | 40.26 | -805,110.00 | -75,3% | |
| 2026-01-20 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -65,832 | 39.35 | -2,590,383.87 | -242,3% | |
| 2026-01-20 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -3,750 | 39.35 | -147,556.50 | -13,8% | |
| 2026-01-16 | Urist Marshall | Officer, EVP, Research & Investments | Open Market Sale | -20,000 | 39.52 | -790,346.00 | -73,9% | |
| 2026-01-09 | Urist Marshall | Officer, EVP, Research & Investments | Open Market Sale | -20,000 | 40.78 | -815,634.00 | -76,3% | |
| 2026-01-02 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -3,750 | 38.42 | -144,058.88 | -13,5% | |
| 2026-01-02 | Urist Marshall | Officer, EVP, Research & Investments | Open Market Sale | -20,000 | 38.48 | -769,650.00 | -72,0% | |
| 2026-01-02 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -65,832 | 38.42 | -2,528,982.36 | -236,5% | |
| 2025-12-26 | Urist Marshall | Officer, EVP, Research & Investments | Open Market Sale | -20,000 | 39.32 | -786,380.00 | -73,6% | |
| 2025-12-19 | Urist Marshall | Officer, EVP, Research & Investments | Open Market Sale | -20,000 | 38.38 | -767,582.00 | -71,8% | |
| 2025-12-18 | Lloyd George W. | Officer, EVP, Investments & CLO | Open Market Sale | -30,654 | 38.50 | -1,180,053.32 | -110,4% | |
| 2025-12-17 | Lloyd George W. | Officer, EVP, Investments & CLO | Open Market Sale | -79,346 | 38.57 | -3,060,280.00 | -286,2% | |
| 2025-12-16 | Urist Marshall | Officer, EVP, Research & Investments | Open Market Sale | -20,000 | 38.32 | -766,420.00 | -71,7% | |
| 2025-12-15 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -3,750 | 38.36 | -143,850.38 | -13,5% | |
| 2025-12-15 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -65,832 | 38.36 | -2,525,322.10 | -236,2% | |
| 2025-12-05 | Urist Marshall | Officer, EVP, Research & Investments | Open Market Sale | -18,242 | 39.15 | -714,223.55 | -66,8% | |
| 2025-12-05 | Urist Marshall | Officer, EVP, Research & Investments | Open Market Sale | -23,334 | 39.15 | -913,591.44 | -85,4% | |
| 2025-12-03 | Lloyd George W. | Officer, EVP, Investments & CLO | Open Market Sale | -110,000 | 39.77 | -4,375,008.00 | -409,2% | |
| 2025-12-01 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -65,832 | 39.87 | -2,624,458.51 | -245,5% | |
| 2025-12-01 | Urist Marshall | Officer, EVP, Research & Investments | Open Market Sale | -23,333 | 39.93 | -931,633.02 | -87,1% | |
| 2025-12-01 | Urist Marshall | Officer, EVP, Research & Investments | Open Market Sale | -18,242 | 39.90 | -727,855.80 | -68,1% | |
| 2025-12-01 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -3,750 | 39.87 | -149,497.50 | -14,0% | |
| 2025-11-24 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -3,126 | 38.67 | -120,882.11 | -11,3% | |
| 2025-11-24 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -55,146 | 38.67 | -2,132,291.78 | -199,4% | |
| 2025-11-24 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -10,686 | 37.96 | -405,644.83 | -37,9% | |
| 2025-11-24 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -624 | 37.96 | -23,686.73 | -2,2% | |
| 2025-11-19 | Lloyd George W. | Officer, EVP, Investments & CLO | Open Market Sale | -2,470 | 39.01 | -96,346.55 | -9,0% | |
| 2025-11-19 | Lloyd George W. | Officer, EVP, Investments & CLO | Open Market Sale | -47,798 | 38.28 | -1,829,650.08 | -171,1% | |
| 2025-11-19 | Lloyd George W. | Officer, EVP, Investments & CLO | Open Market Sale | -47,401 | 38.28 | -1,814,448.66 | -169,7% | |
| 2025-11-19 | Lloyd George W. | Officer, EVP, Investments & CLO | Open Market Sale | -25,530 | 38.28 | -977,260.32 | -91,4% | |
| 2025-11-19 | Lloyd George W. | Officer, EVP, Investments & CLO | Open Market Sale | -4,628 | 39.01 | -180,527.64 | -16,9% | |
| 2025-11-19 | Lloyd George W. | Officer, EVP, Investments & CLO | Open Market Sale | -4,599 | 39.01 | -179,393.65 | -16,8% | |
| 2025-11-19 | Lloyd George W. | Officer, EVP, Investments & CLO | Open Market Sale | -2,770 | 38.29 | -106,051.67 | -9,9% | |
| 2025-11-19 | Lloyd George W. | Officer, EVP, Investments & CLO | Open Market Sale | -230 | 39.03 | -8,977.61 | -0,8% | |
| 2025-11-17 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -3,750 | 39.30 | -147,390.00 | -13,8% | |
| 2025-11-17 | Coyne Terrance P. | Officer, EVP & CFO | Open Market Sale | -65,844 | 39.30 | -2,587,939.16 | -242,1% | |
| 2025-08-11 | Norden Gregory | Director | Open Market Sale | -33,500 | 36.23 | -1,213,748.55 | -113,5% |
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| MORGAN STANLEY | 55,274,069 | 2,135,790,095 | 18.26 |
| Capital International Investors | 31,104,309 | 1,201,870,500 | 10.27 |
| FMR LLC | 26,272,308 | 1,015,161,996 | 8.68 |
| BlackRock, Inc. | 26,188,692 | 1,011,931,068 | 8.65 |
| BAILLIE GIFFORD & CO | 17,008,768 | 657,218,795 | 5.62 |
| Swedbank AB | 11,942,143 | 461,444,406 | 3.94 |
| STATE STREET CORP | 10,649,641 | 411,502,128 | 3.52 |
| VANGUARD GROUP INC | 9,934,612 | 383,873,407 | 3.28 |
| GEODE CAPITAL MANAGEMENT, LLC | 7,719,843 | 297,465,419 | 2.54 |
| CITADEL ADVISORS LLC | 5,360,665 | 207,136,096 | 1.77 |
| VICTORY CAPITAL MANAGEMENT INC | 5,106,905 | 197,330,809 | 1.69 |
| JANE STREET GROUP, LLC | 5,042,709 | 194,850,276 | 1.67 |
| NORTHERN TRUST CORP | 4,003,322 | 154,688,363 | 1.32 |
| NORGES BANK | 3,414,165 | 131,923,336 | 1.13 |
| Patient Capital Management, LLC | 3,333,675 | 128,813,194 | 1.10 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3,313,265 | 128,024,560 | 1.09 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3,118,865 | 120,512,944 | 1.03 |
| Legal & General Group Plc | 3,088,098 | 119,324,106 | 1.02 |
| NEW SOUTH CAPITAL MANAGEMENT INC | 2,928,778 | 113,167,982 | 0.97 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,913,398 | 112,573,699 | 0.96 |